Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cell And Molecular Tissue Engineering LLC is managing 1 pending office action within the Chemistry & Materials technology area. This action is assigned to 1 distinct examiner, BOWMAN, ANDREW J. The portfolio involves 1 distinct art unit, indicating that the company's active matter is being reviewed within a specific technical division of the patent office. This concentration allows for a prosecution strategy that is highly specialized for the Chemistry & Materials sector and the requirements of that single art unit.
The busiest examiner for the portfolio is BOWMAN, ANDREW J, who is responsible for the 1 pending office action. Since the total number of pending office actions is 1, this examiner handles the company's entire current workload. Practitioners should focus on the examiner's specific history and the technical standards of the art unit to anticipate the outcome of this matter. The singular nature of the current prosecution means that the company's immediate success in this area depends on the feedback and decisions of this one official.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOWMAN, ANDREW J | 1 | 65.9% | +13.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18729359 | Methods and Products to Detect, Minimize and Treat TRAP-Related Tissue Reactions and Tissue Injury Associated With Medical Devices | BOWMAN, ANDREW J | 147d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18729359 | Methods and Products to Detect, Minimize and Treat TRAP-Related Tissue Reactions and Tissue Injury Associated With Medical Devices | BOWMAN, ANDREW J | 147d overdue |
| Art Unit | Apps |
|---|---|
| 1717 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18729359 | Methods and Products to Detect, Minimize and Treat TRAP-Related Tissue Reactions and Tissue Injury Associated With Medical Devices | BOWMAN, ANDREW J | 1717 | §102§103 | Final Rejection | 147d overdue | Pending | Jul 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial